Using the publicly available gene expression data from Larsen et al. (GSE40115), which includes gene expression profiling of 183 breast tumors, including 33 with BRCA1 germline mutation, 22 with BRCA2 germline mutation, and the remainder sporadic [21], we determined levels of FOXC1 between BLBC and non-BLBC for the BRCA1-mutant (Figure 2A) and BRCA2-mutant (Figure 2B) tumors. The gene discussed is BRCA2; the disease is breast neoplasm.